Published in Antimicrob Agents Chemother on May 30, 2017
Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis (2009) 18.19
An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods (1999) 17.06
Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc (2008) 7.92
Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis (2003) 7.09
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis (2015) 4.07
A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nat Protoc (2008) 3.46
In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature. Mycopathologia (2001) 2.64
Invasive fungal infections: a review of epidemiology and management options. J Med Microbiol (2006) 2.37
In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi. J Clin Microbiol (2001) 2.13
An anti-infective peptide that selectively modulates the innate immune response. Nat Biotechnol (2007) 1.97
Organ-specific innate immune responses in a mouse model of invasive candidiasis. J Innate Immun (2010) 1.94
Testing conditions for determination of minimum fungicidal concentrations of new and established antifungal agents for Aspergillus spp.: NCCLS collaborative study. J Clin Microbiol (2002) 1.72
Specific recognition of Candida albicans by macrophages requires galectin-3 to discriminate Saccharomyces cerevisiae and needs association with TLR2 for signaling. J Immunol (2006) 1.63
Broad-spectrum anti-biofilm peptide that targets a cellular stress response. PLoS Pathog (2014) 1.58
C-type lectin receptors Dectin-3 and Dectin-2 form a heterodimeric pattern-recognition receptor for host defense against fungal infection. Immunity (2013) 1.46
Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities. Int J Antimicrob Agents (2013) 1.40
Fungal chitin dampens inflammation through IL-10 induction mediated by NOD2 and TLR9 activation. PLoS Pathog (2014) 1.25
Structural studies of a peptide with immune modulating and direct antimicrobial activity. Chem Biol (2010) 1.24
Live Candida albicans suppresses production of reactive oxygen species in phagocytes. Infect Immun (2008) 1.16
Potential therapeutic application of host defense peptides. Methods Mol Biol (2010) 1.15
A broad-spectrum antibiofilm peptide enhances antibiotic action against bacterial biofilms. Antimicrob Agents Chemother (2014) 1.13
Epidemiology, species distribution, antifungal susceptibility, and outcome of candidemia across five sites in Italy and Spain. J Clin Microbiol (2013) 1.10
Candida and candidiasis in HIV-infected patients: where commensalism, opportunistic behavior and frank pathogenicity lose their borders. AIDS (2012) 1.10
Innate defense regulator peptide 1018 in wound healing and wound infection. PLoS One (2012) 1.06
Effective adjunctive therapy by an innate defense regulatory peptide in a preclinical model of severe malaria. Sci Transl Med (2012) 1.05
A rapid and sensitive hemolysis neutralization assay for palytoxin. Toxicon (1993) 0.99
Ability of innate defence regulator peptides IDR-1002, IDR-HH2 and IDR-1018 to protect against Mycobacterium tuberculosis infections in animal models. PLoS One (2013) 0.96
The immunology of host defence peptides: beyond antimicrobial activity. Nat Rev Immunol (2016) 0.94
The innate defense regulator peptides IDR-HH2, IDR-1002, and IDR-1018 modulate human neutrophil functions. J Leukoc Biol (2013) 0.93
Effects of human neutrophil peptide-1 on the expression of interstitial collagenase and type I collagen in human dermal fibroblasts. Arch Dermatol Res (2002) 0.91
Peptide IDR-1018: modulating the immune system and targeting bacterial biofilms to treat antibiotic-resistant bacterial infections. J Pept Sci (2014) 0.91
Candida albicans specializations for iron homeostasis: from commensalism to virulence. Curr Opin Microbiol (2013) 0.90
Innate defense regulator peptide 1018 protects against perinatal brain injury. Ann Neurol (2014) 0.89
Synthetic cationic peptide IDR-1018 modulates human macrophage differentiation. PLoS One (2013) 0.88
Antibiofilm peptides increase the susceptibility of carbapenemase-producing Klebsiella pneumoniae clinical isolates to β-lactam antibiotics. Antimicrob Agents Chemother (2015) 0.88
A Novel Small Molecule Inhibitor of Candida albicans Biofilm Formation, Filamentation and Virulence with Low Potential for the Development of Resistance. NPJ Biofilms Microbiomes (2015) 0.85
Immunomodulatory Peptide IDR-1018 Decreases Implant Infection and Preserves Osseointegration. Clin Orthop Relat Res (2015) 0.82
Spectrophotometric determination of protein concentration. Curr Protoc Toxicol (2004) 0.79
How to treat fungal infections in ICU patients. BMC Infect Dis (2015) 0.78
Screening of fullerene toxicity by hemolysis assay. Methods Mol Biol (2012) 0.78
Immune Response Profile against Persistent Endodontic Pathogens Candida albicans and Enterococcus faecalis In Vitro. J Endod (2015) 0.77
Epidemiology, species distribution, antifungal susceptibility, and ERG11 mutations of Candida species isolated from pregnant Chinese Han women. Genet Mol Res (2016) 0.76
Dissecting Candida albicans Infection from the Perspective of C. albicans Virulence and Omics Approaches on Host-Pathogen Interaction: A Review. Int J Mol Sci (2016) 0.75